BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 23432943)

  • 21. Characterization of baboon anti-porcine IgG antibodies during acute vascular rejection of porcine kidney xenograft.
    Dehoux JP; de la Parra B; Latinne D; Bazin H; Gianello P
    Xenotransplantation; 2002 Sep; 9(5):338-49. PubMed ID: 12199865
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Autoantibodies to LG3 are associated with poor long-term survival after liver retransplantation.
    Xu Q; McAlister VC; House AA; Molinari M; Leckie S; Zeevi A
    Clin Transplant; 2021 Jul; 35(7):e14318. PubMed ID: 33871888
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Emerging Importance of Non-HLA Autoantibodies in Kidney Transplant Complications.
    Cardinal H; Dieudé M; Hébert MJ
    J Am Soc Nephrol; 2017 Feb; 28(2):400-406. PubMed ID: 27798244
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Non-HLA antibodies against endothelial targets bridging allo- and autoimmunity.
    Dragun D; Catar R; Philippe A
    Kidney Int; 2016 Aug; 90(2):280-288. PubMed ID: 27188505
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Non-HLA agonistic anti-angiotensin II type 1 receptor antibodies induce a distinctive phenotype of antibody-mediated rejection in kidney transplant recipients.
    Lefaucheur C; Viglietti D; Bouatou Y; Philippe A; Pievani D; Aubert O; Duong Van Huyen JP; Taupin JL; Glotz D; Legendre C; Loupy A; Halloran PF; Dragun D
    Kidney Int; 2019 Jul; 96(1):189-201. PubMed ID: 31005275
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Early Acute Microvascular Kidney Transplant Rejection in the Absence of Anti-HLA Antibodies Is Associated with Preformed IgG Antibodies against Diverse Glomerular Endothelial Cell Antigens.
    Delville M; Lamarthée B; Pagie S; See SB; Rabant M; Burger C; Gatault P; Giral M; Thaunat O; Arzouk N; Hertig A; Hazzan M; Matignon M; Mariat C; Caillard S; Kamar N; Sayegh J; Westeel PF; Garrouste C; Ladrière M; Vuiblet V; Rivalan J; Merville P; Bertrand D; Le Moine A; Duong Van Huyen JP; Cesbron A; Cagnard N; Alibeu O; Satchell SC; Legendre C; Zorn E; Taupin JL; Charreau B; Anglicheau D
    J Am Soc Nephrol; 2019 Apr; 30(4):692-709. PubMed ID: 30850439
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment with a short course of LF 15-0195 and continuous cyclosporin A attenuates acute xenograft rejection in a rat-to-mouse cardiac transplantation model.
    Wang H; Hosiawa KA; Garcia B; Shum JB; Dutartre P; Kelvin DJ; Zhong R
    Xenotransplantation; 2003 Jul; 10(4):325-36. PubMed ID: 12795681
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pretransplant C3d-Fixing Donor-Specific Anti-HLA Antibodies Are Not Associated with Increased Risk for Kidney Graft Failure.
    Kamburova EG; Wisse BW; Joosten I; Allebes WA; van der Meer A; Hilbrands LB; Baas MC; Spierings E; Hack CE; van Reekum FE; van Zuilen AD; Verhaar MC; Bots ML; Drop ACAD; Plaisier L; Seelen MAJ; Sanders JS; Hepkema BG; Lambeck AJA; Bungener LB; Roozendaal C; Tilanus MGJ; Voorter CE; Wieten L; van Duijnhoven EM; Gelens MACJ; Christiaans MHL; van Ittersum FJ; Nurmohamed SA; Lardy NM; Swelsen W; van der Pant KAMI; van der Weerd NC; Ten Berge IJM; Bemelman FJ; Hoitsma AJ; van der Boog PJM; de Fijter JW; Betjes MGH; Heidt S; Roelen DL; Claas FH; Otten HG
    J Am Soc Nephrol; 2018 Sep; 29(9):2279-2285. PubMed ID: 30049681
    [No Abstract]   [Full Text] [Related]  

  • 29. Renal transplant patients with preformed anti-HLA antibodies: early biopsy findings and clinical outcomes.
    Sousa MV; Zollner RL; Mazzali M
    J Bras Nefrol; 2019 Sep; 42(2):201-210. PubMed ID: 31528982
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In the absence of natural killer cell activation donor-specific antibody mediates chronic, but not acute, kidney allograft rejection.
    Yagisawa T; Tanaka T; Miyairi S; Tanabe K; Dvorina N; Yokoyama WM; Valujskikh A; Baldwin WM; Fairchild RL
    Kidney Int; 2019 Feb; 95(2):350-362. PubMed ID: 30503624
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characteristics of Circulating Donor Human Leukocyte Antigen-specific Immunoglobulin G Antibodies Predictive of Acute Antibody-mediated Rejection and Kidney Allograft Failure.
    Kannabhiran D; Lee J; Schwartz JE; Friedlander R; Aull M; Muthukumar T; Campbell S; Epstein D; Seshan SV; Kapur S; Sharma VK; Suthanthiran M; Dadhania D
    Transplantation; 2015 Jun; 99(6):1156-64. PubMed ID: 25629531
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Absence of Activation-induced Cytidine Deaminase, a Regulator of Class Switch Recombination and Hypermutation in B Cells, Suppresses Aorta Allograft Vasculopathy in Mice.
    Nakanishi T; Xu X; Wynn C; Yamada T; Pan F; Erickson L; Teo H; Nakagawa T; Masunaga T; Abe J; Akamatsu M; Tamura K; Jiang H
    Transplantation; 2015 Aug; 99(8):1598-605. PubMed ID: 25769064
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cyclosporine immunosuppression does not prevent the production of donor-specific antibody capable of mediating allograft vasculopathy.
    Gareau AJ; Nashan B; Hirsch GM; Lee TD
    J Heart Lung Transplant; 2012 Aug; 31(8):874-80. PubMed ID: 22554675
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Markers of graft microvascular endothelial injury may identify harmful donor-specific anti-HLA antibodies and predict kidney allograft loss.
    Louis K; Hertig A; Taupin JL; Buob D; Jamme M; Brocheriou I; Luque Y; Jouanneau C; Ouali N; Audouin M; Rondeau E; Xu-Dubois YC
    Am J Transplant; 2019 Sep; 19(9):2434-2445. PubMed ID: 30836425
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acute Rejection, Kidney Allograft Function, and Graft Survival in Patients with Circulating Pre-Transplant IgG Antibodies Directed Against Donor HLA-A, -B, or -C Locus Determined Antigens.
    Abuhelaiqa E; Friedlander R; Aull M; Putheti P; Sharma V; Suthanthiran M; Dadhania D
    Clin Transpl; 2016; 32():83-91. PubMed ID: 28564525
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cell-mediated and humoral acute vascular rejection and graft loss: A registry study.
    Teo RZ; Wong G; Russ GR; Lim WH
    Nephrology (Carlton); 2016 Feb; 21(2):147-55. PubMed ID: 26243593
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anti-huCD20 antibody therapy for antibody-mediated rejection of renal allografts in a mouse model.
    Abe T; Ishii D; Gorbacheva V; Kohei N; Tsuda H; Tanaka T; Dvorina N; Nonomura N; Takahara S; Valujskikh A; Baldwin WM; Fairchild RL
    Am J Transplant; 2015 May; 15(5):1192-204. PubMed ID: 25731734
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Isolated v-lesion represents a benign phenotype of vascular rejection of the kidney allograft - a retrospective study.
    Novotny M; Hruba P; Vichova P; Maluskova J; Honsova E; Viklicky O; Wohlfahrtova M
    Transpl Int; 2018 Oct; 31(10):1153-1163. PubMed ID: 29855106
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Endothelial cell antibodies associated with novel targets and increased rejection.
    Jackson AM; Sigdel TK; Delville M; Hsieh SC; Dai H; Bagnasco S; Montgomery RA; Sarwal MM
    J Am Soc Nephrol; 2015 May; 26(5):1161-71. PubMed ID: 25381426
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anti-cell surface endothelial antibodies in sera from cardiac and kidney transplant recipients: association with chronic rejection.
    Ferry BL; Welsh KI; Dunn MJ; Law D; Proctor J; Chapel H; Yacoub MH; Rose ML
    Transpl Immunol; 1997 Mar; 5(1):17-24. PubMed ID: 9106330
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.